Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2004, p. 888-890, Vol. 42, No. 2
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.2.888-890.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Laboratoire de Microbiologie Pharmaceutique, UPRES-EA 1254, Université de Rennes 1, 35043 Rennes ,1 Equipe de Biologie Buccale, UPRES-EA 1256, UFR Odontologie, Université de Rennes 1, 35000 Rennes, France2
Received 24 June 2003/ Returned for modification 25 August 2003/ Accepted 2 October 2003
A beta-lactamase gene (cfxA3, 966 bp) was isolated from a beta-lactam-resistant Capnocytophaga ochracea clinical isolate and amplified using primers from the cfxA gene of Bacteroides vulgatus. The MICs of third-generation cephalosporins were much higher than those of the transconjugant Escherichia coli strain. The deduced protein sequence, by comparison with CfxA2 of Prevotella intermedia, had a Y239D substitution and possessed the characteristics of a class A, group 2e beta-lactamase.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|